← @monaco_biotech

$CANF

BULLISH2026-04-30
Price around the call
↑ 2026-04-30
By horizon✓ hit+0.7%
1d
✓ +13.7%
5d
✓ +17.4%
21d
✓ +0.7%
Original post
Monaco · 2026-04-30

$CANF +12% 📈 pre-market Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months • BioPharmCatalyst https://t.co/PWwBwQGKbN

View on X ↗